Consider referring patients with relatives with type 1 diabetes for islet autoantibody testing in the context of clinical research trials.
Consider prescribing metformin for patients with prediabetes, particularly for patients with a body mass index 35 kg/m2 or greater, patients younger than 60 years, and women with a history of gestational diabetes.
For patients with type 2 diabetes with established cardiovascular disease or who are considered at high risk, with chronic kidney disease, or with heart failure, prescribe a glucagon-like peptide 1 (GLP-1) receptor agonist or a sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor as part of the drug regimen.
Consider use of an insulin pump for the management of type 1 diabetes in adults, adolescents, and children who are able to safely manage the device.
Consider use of an automated insulin delivery system for the management of type 1 diabetes in adults who have the skills to use such a system.
Resources
Strength of Evidence: SORT A
Source: American Diabetes Association, reference 2
Strength of Evidence: SORT A
Source: American Diabetes Association, reference 14
Strength of Evidence: SORT A
Source: American Diabetes Association, reference 10
Strength of Evidence: SORT A
Source: American Diabetes Association, reference 104
Strength of Evidence: SORT A
Source: American Diabetes Association, reference 104
Website: https://care.diabetesjournals.org/content/43/Supplement_1/S14
Website: https://clinical.diabetesjournals.org/content/38/1/10
Website: https://care.diabetesjournals.org/content/43/Supplement_1/S98
Website: https://care.diabetesjournals.org/content/43/Supplement_1/S77
Website: https://care.diabetesjournals.org/content/43/Supplement_1/S77
Subscribe
From $335- Immediate, unlimited access to all FP Essentials content
- 60 CME credits/year
- AAFP app access
- Print delivery available
Edition Access
$59- Immediate, unlimited access to this edition's content
- 5 CME credits
- AAFP app access
- Print delivery available
